1. Home
  2. SPRO vs PERF Comparison

SPRO vs PERF Comparison

Compare SPRO & PERF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.12

Market Cap

156.3M

Sector

Health Care

ML Signal

HOLD

Logo Perfect Corp.

PERF

Perfect Corp.

N/A

Current Price

$1.74

Market Cap

168.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SPRO
PERF
Founded
2013
2015
Country
United States
Taiwan
Employees
N/A
353
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
156.3M
168.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SPRO
PERF
Price
$2.12
$1.74
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.6M
54.1K
Earning Date
05-13-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
111.81
N/A
EPS
N/A
N/A
Revenue
$66,802,000.00
N/A
Revenue This Year
N/A
$12.93
Revenue Next Year
$300.00
$9.44
P/E Ratio
N/A
$26.42
Revenue Growth
39.24
N/A
52 Week Low
$1.80
$1.24
52 Week High
$3.08
$2.67

Technical Indicators

Market Signals
Indicator
SPRO
PERF
Relative Strength Index (RSI) 37.66 80.22
Support Level $1.90 $1.89
Resistance Level $2.45 $2.15
Average True Range (ATR) 0.11 0.03
MACD -0.00 0.02
Stochastic Oscillator 25.74 94.15

Price Performance

Historical Comparison
SPRO
PERF

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About PERF Perfect Corp.

Perfect Corp is engaged in the beauty and fashion tech revolution, providing omni-channel integrated solutions. The company runs a hybrid business model of direct consumer business (B2C business) and enterprise business (B2B business). For B2C businesses, the company offers six mobile apps under the "YouCam" suite, along with one online editing service tool, YouCam Online Editor, featuring AI and AR technologies. For B2B businesses, the company offers AI and AR-powered solutions tailored for the beauty and fashion industry. Geographically, the company has a presence in the United States, Americas-other, France, Japan, and Others. The company generates the majority of its revenue from the United States.

Share on Social Networks: